Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04515810 · ClinicalTrials.gov registry record · NA

Mobile Health Application (PACT) to Improve Engagement in Advance Care Planning

A NA study of Malignant Solid Neoplasm, sponsored by Fred Hutchinson Cancer Center.

Recruiting
Registry status
NA
Development phase
400
Enrollment target
4
Study locations

NCT04515810: Recruiting NA study of Malignant Solid Neoplasm, sponsored by Fred Hutchinson Cancer Center.

NCT04515810 is a NA study of Malignant Solid Neoplasm that is actively recruiting participants, run by Fred Hutchinson Cancer Center. The registered enrollment target is 400 participants, below the 1,139-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (65% lower). The trial reports 4 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04515810, a NA study of Malignant Solid Neoplasm, is actively recruiting participants, sponsored by Fred Hutchinson Cancer Center.

RECRUITING
Registry status
NA
Development phase
400 participants
Enrollment target
4
Study locations

Study Summary

This clinical trial tests a new mobile health application (app) called Planning Advance Care Together (PACT) to help people with cancer talk about and plan for advance care planning (the care they would want if they were unable to communicate) with their loved ones and doctors. The development of the PACT mobile app may help future patients incorporate their social network (typically, but not exclusively, family) into the advance care planning process.

Primary Outcome

Will assess the percentage of eligible approached patients who consent to enroll in the study

Conditions Studied

Interventions

  • OTHER Questionnaire Administration
  • OTHER Best Practice
  • OTHER Internet-Based Intervention

Study Locations (4)

New York

  • Northwell Health - Manhasset
  • Mount Sinai Hospital - New York
  • NYP/Weill Cornell Medical Center - New York

Washington

  • Fred Hutch/University of Washington Cancer Consortium - Seattle

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2025-02-18
Est. Completion 2026-12-31
Phase NA
Fred Hutchinson Cancer Center

483 total trials

What NCT04515810 shows while recruiting

NCT04515810 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 1,139-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (65% lower).

The record links to 1 condition, with Malignant Solid Neoplasm appearing as the primary indexed condition, and to 3 interventions - of which Questionnaire Administration is the first listed.

NCT04515810 reports a single indexed study location in New York, Washington.

Frequently Asked Questions

What is clinical trial NCT04515810 about?

NCT04515810 is a clinical study titled "Mobile Health Application (PACT) to Improve Engagement in Advance Care Planning". This clinical trial tests a new mobile health application (app) called Planning Advance Care Together (PACT) to help people with cancer talk about and plan for advance care planning (the care they would want if they were unable to communicate) with their loved ones and doctors. The development of th...

What is the current status of trial NCT04515810?

This trial is currently recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2025-02-18. Estimated completion is 2026-12-31.

What conditions does trial NCT04515810 study?

This clinical trial studies the following conditions: Malignant Solid Neoplasm.

What interventions are being tested in trial NCT04515810?

The interventions under investigation include: Questionnaire Administration (OTHER), Best Practice (OTHER), Internet-Based Intervention (OTHER).

Who is sponsoring clinical trial NCT04515810?

This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04515810 being conducted?

This trial has 4 study locations across New York, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Malignant Solid Neoplasm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04515810's enrollment target sits among peer trials

400 36th of 176 higher than 139 of 176 other Malignant Solid Neoplasm trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Malignant Solid Neoplasm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01665326 · 400 participants

    Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease

  • NCT02108054 · 400 participants · NA

    Behavioral and Functional Task Development, Implementation, and Testing

  • NCT02216500 · 400 participants · NA

    Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy

  • NCT02250352 · 400 participants

    Core Biopsies for Establishing a Breast Tumor Tissue Repository

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04515810, the US trial registry maintained by the National Library of Medicine. NCT04515810 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.